Detalhe da pesquisa
1.
TGFßR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.
Int J Exp Pathol
; 105(2): 64-74, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38328944
2.
TGF-ß2 silencing to target biliary-derived liver diseases.
Gut
; 69(9): 1677-1690, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992593
3.
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).
BMC Cancer
; 19(1): 231, 2019 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871493
4.
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma.
Clin Sci (Lond)
; 128(11): 761-74, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25602745
5.
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
Sci Immunol
; 9(95): eadj7970, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701193
6.
Molecular code for transmembrane-helix recognition by the Sec61 translocon.
Nature
; 450(7172): 1026-30, 2007 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-18075582
7.
Characteristics and outcome of patients with small bowel adenocarcinoma (SBA).
J Cancer Res Clin Oncol
; 149(8): 4579-4590, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36163558
8.
TGF-ß signaling in onset and progression of hepatocellular carcinoma.
Dig Dis
; 30(5): 514-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23108308
9.
Insertion of short transmembrane helices by the Sec61 translocon.
Proc Natl Acad Sci U S A
; 106(28): 11588-93, 2009 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19581593
10.
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
Lancet Healthy Longev
; 3(6): e417-e427, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098320
11.
Highlight report: pluripotent stem cells in translational research.
Arch Toxicol
; 90(12): 3145-3146, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27743009
12.
TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I.
J Hepatol
; 52(3): 407-16, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20129692
13.
Alcohol, signaling, and ECM turnover.
Alcohol Clin Exp Res
; 34(1): 4-18, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19860812
14.
Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.
J Gastroenterol Hepatol
; 23 Suppl 1: S122-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18336655
15.
TGF-ß1 and TGF-ß2 abundance in liver diseases of mice and men.
Oncotarget
; 7(15): 19499-518, 2016 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799667
16.
A scalable, GFP-based pipeline for membrane protein overexpression screening and purification.
Protein Sci
; 14(8): 2011-7, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15987891
17.
Comparative analysis of TGF-ß/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines.
PLoS One
; 8(8): e72252, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23991075
18.
TGF-beta signaling in alcohol induced hepatic injury.
Front Biosci (Landmark Ed)
; 15(2): 740-9, 2010 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20036843
19.
Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.
World J Gastroenterol
; 16(41): 5211-24, 2010 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21049555
20.
Loss of TGF-beta dependent growth control during HSC transdifferentiation.
Biochem Biophys Res Commun
; 353(3): 841-7, 2007 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-17204247